Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 240

1.

Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters.

Sexton M, Cudaback E, Abdullah RA, Finnell J, Mischley LK, Rozga M, Lichtman AH, Stella N.

Inflammopharmacology. 2014 Aug 19. [Epub ahead of print]

PMID:
25135301
[PubMed - as supplied by publisher]
2.

Delta FosB and AP-1-mediated transcription modulate cannabinoid CB1 receptor signaling and desensitization in striatal and limbic brain regions.

Lazenka MF, David BG, Lichtman AH, Nestler EJ, Selley DE, Sim-Selley LJ.

Biochem Pharmacol. 2014 Aug 2. pii: S0006-2952(14)00445-6. doi: 10.1016/j.bcp.2014.07.024. [Epub ahead of print]

PMID:
25093286
[PubMed - as supplied by publisher]
3.

Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus.

Parker LA, Niphakis MJ, Downey R, Limebeer CL, Rock EM, Sticht MA, Morris H, Abdullah RA, Lichtman AH, Cravatt BF.

Psychopharmacology (Berl). 2014 Aug 3. [Epub ahead of print]

PMID:
25085768
[PubMed - as supplied by publisher]
4.

Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models.

Grim TW, Ghosh S, Hsu KL, Cravatt BF, Kinsey SG, Lichtman AH.

Pharmacol Biochem Behav. 2014 Jul 21;124C:405-411. doi: 10.1016/j.pbb.2014.07.008. [Epub ahead of print]

PMID:
25058512
[PubMed - as supplied by publisher]
5.

Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory.

Hait NC, Wise LE, Allegood JC, O'Brien M, Avni D, Reeves TM, Knapp PE, Lu J, Luo C, Miles MF, Milstien S, Lichtman AH, Spiegel S.

Nat Neurosci. 2014 Jul;17(7):971-80. doi: 10.1038/nn.3728. Epub 2014 May 25.

PMID:
24859201
[PubMed - in process]
6.

Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents.

Wiley JL, Walentiny DM, Wright MJ Jr, Beardsley PM, Burston JJ, Poklis JL, Lichtman AH, Vann RE.

Eur J Pharmacol. 2014 Aug 15;737:97-105. doi: 10.1016/j.ejphar.2014.05.013. Epub 2014 May 22.

PMID:
24858366
[PubMed - in process]
7.

Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice.

Schlosburg JE, Kinsey SG, Ignatowska-Jankowska B, Ramesh D, Abdullah RA, Tao Q, Booker L, Long JZ, Selley DE, Cravatt BF, Lichtman AH.

J Pharmacol Exp Ther. 2014 Aug;350(2):196-204. doi: 10.1124/jpet.114.212753. Epub 2014 May 21.

PMID:
24849924
[PubMed - in process]
8.

Development of a high-performance liquid chromatography-tandem mass spectrometry method for the identification and quantification of CP-47,497, CP-47,497-C8 and JWH-250 in mouse brain.

Samano KL, Poklis JL, Lichtman AH, Poklis A.

J Anal Toxicol. 2014 Jul-Aug;38(6):307-14. doi: 10.1093/jat/bku043. Epub 2014 May 9.

PMID:
24816398
[PubMed - in process]
9.

In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569.

Gamage TF, Ignatowska-Jankowska BM, Wiley JL, Abdelrahman M, Trembleau L, Greig IR, Thakur GA, Tichkule R, Poklis J, Ross RA, Pertwee RG, Lichtman AH.

Behav Pharmacol. 2014 Apr;25(2):182-5. doi: 10.1097/FBP.0000000000000027.

PMID:
24603340
[PubMed - in process]
Free PMC Article
10.

Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats.

Kwilasz AJ, Abdullah RA, Poklis JL, Lichtman AH, Negus SS.

Behav Pharmacol. 2014 Apr;25(2):119-29. doi: 10.1097/FBP.0000000000000023.

PMID:
24583930
[PubMed - in process]
11.

Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells.

Emery SM, Alotaibi MR, Tao Q, Selley DE, Lichtman AH, Gewirtz DA.

J Pharmacol Exp Ther. 2014 Feb;348(2):293-302. doi: 10.1124/jpet.113.205120. Epub 2013 Nov 20.

PMID:
24259678
[PubMed - indexed for MEDLINE]
12.

Attenuation of anticipatory nausea in a rat model of contextually elicited conditioned gaping by enhancement of the endocannabinoid system.

Limebeer CL, Abdullah RA, Rock EM, Imhof E, Wang K, Lichtman AH, Parker LA.

Psychopharmacology (Berl). 2014 Feb;231(3):603-12. doi: 10.1007/s00213-013-3282-7. Epub 2013 Sep 17.

PMID:
24043345
[PubMed - in process]
13.

The influence of innate and adaptive immune responses on atherosclerosis.

Witztum JL, Lichtman AH.

Annu Rev Pathol. 2014;9:73-102. doi: 10.1146/annurev-pathol-020712-163936. Epub 2013 Aug 7. Review.

PMID:
23937439
[PubMed - indexed for MEDLINE]
14.

In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: antinociceptive activity without cannabimimetic side effects.

Ignatowska-Jankowska BM, Ghosh S, Crowe MS, Kinsey SG, Niphakis MJ, Abdullah RA, Tao Q, O' Neal ST, Walentiny DM, Wiley JL, Cravatt BF, Lichtman AH.

Br J Pharmacol. 2014 Mar;171(6):1392-407. doi: 10.1111/bph.12298.

PMID:
23848221
[PubMed - in process]
15.

The heart of the matter: protection of the myocardium from T cells.

Lichtman AH.

J Autoimmun. 2013 Sep;45:90-6. doi: 10.1016/j.jaut.2013.05.004. Epub 2013 Jun 28. Review.

PMID:
23810579
[PubMed - indexed for MEDLINE]
16.

Immune effector mechanisms implicated in atherosclerosis: from mice to humans.

Libby P, Lichtman AH, Hansson GK.

Immunity. 2013 Jun 27;38(6):1092-104. doi: 10.1016/j.immuni.2013.06.009. Review. Erratum in: Immunity. 2013 Aug 22;39(2):413.

PMID:
23809160
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Two sides to every proinflammatory coin: new insights into the role of dendritic cells in the regulation of T-cell driven autoimmune myocarditis.

Griffin GK, Lichtman AH.

Circulation. 2013 Jun 11;127(23):2257-60. doi: 10.1161/CIRCULATIONAHA.113.003261. Epub 2013 May 13. No abstract available.

PMID:
23671207
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The cannabinoid CB2 receptor is necessary for nicotine-conditioned place preference, but not other behavioral effects of nicotine in mice.

Ignatowska-Jankowska BM, Muldoon PP, Lichtman AH, Damaj MI.

Psychopharmacology (Berl). 2013 Oct;229(4):591-601. doi: 10.1007/s00213-013-3117-6. Epub 2013 May 8.

PMID:
23652588
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Rational design of fatty acid amide hydrolase inhibitors that act by covalently bonding to two active site residues.

Otrubova K, Brown M, McCormick MS, Han GW, O'Neal ST, Cravatt BF, Stevens RC, Lichtman AH, Boger DL.

J Am Chem Soc. 2013 Apr 24;135(16):6289-99. doi: 10.1021/ja4014997. Epub 2013 Apr 12.

PMID:
23581831
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1-mediated antinociceptive and gastroprotective effects.

Kinsey SG, Wise LE, Ramesh D, Abdullah R, Selley DE, Cravatt BF, Lichtman AH.

J Pharmacol Exp Ther. 2013 Jun;345(3):492-501. doi: 10.1124/jpet.112.201426. Epub 2013 Feb 14.

PMID:
23412396
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk